Jonathan Ledermann

Jonathan Andrew Ledermann, MD

-

Panelist

Biography

Jonathan Ledermann BSc MD FRCP FMedSci is a Professor of Medical Oncology at UCL Cancer Institute, University College London, and a Consultant Medical Oncologist at UCL Hospitals, London, UK where he has worked for more than 35 years. For more than 20 years, he was the Director of the Cancer Research UK & UCL Cancer Trials Centre He specialises in the treatment of gynaecological cancers and has led several national and international trials in ovarian cancer. He is a Fellow of the Academy of Medical Sciences in the UK and was a past Vice-President of ESGO and a past chair of the NCRI UK Gynaecological Cancer Trials Group and Rare Tumour Group of the Gynaecological Cancer Intergroup. He has been on Council of IGCS and the BGCS (British Gynaecological Cancer Society). He is the former subject Editor for ESMO Gynaecological Cancer Practice Guidelines. He serves on Editorial Boards of several scientific journals and has published widely in the areas of clinical trials in gynaecological cancers, experimental therapeutics, guidelines, and education in gynaecological malignancies.

Financial Disclosure

Awaiting faculty disclosure.